Tom specialises in commercial litigation, intellectual property and media law.
Tom is an experienced litigator who advises on a wide range of complex commercial disputes. He has particular expertise in intellectual property, defamation, privacy, company, trust and consumer protection law.
He is highly recommended by Legal 500 Asia Pacific 2020, and is recognised as a Rising Star by both Legal 500 Asia Pacific 2020 and IP Stars 2019. Tom is a co-author of the patent infringement section in New Zealand’s leading intellectual property commentary, Intellectual Property Law (LexisNexis).
He joined Chapman Tripp in 2018 from Shortland Chambers where he was a barrister. Before that Tom was a Judges' Clerk and Clerk to the Rules Committee.
represented Fisher & Paykel Healthcare in the High Court defending its health technology products against patent infringement claims and in challenging the validity of the asserted patents
appeared in the High Court and Court of Appeal establishing that a director of a law firm was liable for breaches of the Fair Trading Act 1986 concerning financing the share purchase of Orcon
acted for MediaWorks in the High Court and Court of Appeal defending a claim to journalistic source protection
appeared in the Supreme Court in a high-profile defamation case about qualified privilege, damages awards and the circumstances when a jury's verdict can be set aside
advised a range of entities on issues under the Overseas Investment Act 2005
appeared in the Supreme Court successfully arguing that a commercial property was not held in a beneficial trust and the transfer of that property was intended to defeat the respondent's rights in the property
acted for a leading New Zealand designer in prosecuting copyright infringement proceedings in the High Court
appeared in the High Court challenging the enforcement in New Zealand of a multi-million dollar award by an overseas tribunal, and
represented an international production company in a dispute over a former television channel, intellectual property rights and unpaid royalties.